MCM7_HUMAN - dbPTM
MCM7_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MCM7_HUMAN
UniProt AC P33993
Protein Name DNA replication licensing factor MCM7
Gene Name MCM7
Organism Homo sapiens (Human).
Sequence Length 719
Subcellular Localization Nucleus.
Protein Description Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. Required for S-phase checkpoint activation upon UV-induced damage..
Protein Sequence MALKDYALEKEKVKKFLQEFYQDDELGKKQFKYGNQLVRLAHREQVALYVDLDDVAEDDPELVDSICENARRYAKLFADAVQELLPQYKEREVVNKDVLDVYIEHRLMMEQRSRDPGMVRSPQNQYPAELMRRFELYFQGPSSNKPRVIREVRADSVGKLVTVRGIVTRVSEVKPKMVVATYTCDQCGAETYQPIQSPTFMPLIMCPSQECQTNRSGGRLYLQTRGSRFIKFQEMKMQEHSDQVPVGNIPRSITVLVEGENTRIAQPGDHVSVTGIFLPILRTGFRQVVQGLLSETYLEAHRIVKMNKSEDDESGAGELTREELRQIAEEDFYEKLAASIAPEIYGHEDVKKALLLLLVGGVDQSPRGMKIRGNINICLMGDPGVAKSQLLSYIDRLAPRSQYTTGRGSSGVGLTAAVLRDSVSGELTLEGGALVLADQGVCCIDEFDKMAEADRTAIHEVMEQQTISIAKAGILTTLNARCSILAAANPAYGRYNPRRSLEQNIQLPAALLSRFDLLWLIQDRPDRDNDLRLAQHITYVHQHSRQPPSQFEPLDMKLMRRYIAMCREKQPMVPESLADYITAAYVEMRREAWASKDATYTSARTLLAILRLSTALARLRMVDVVEKEDVNEAIRLMEMSKDSLLGDKGQTARTQRPADVIFATVRELVSGGRSVRFSEAEQRCVSRGFTPAQFQAALDEYEELNVWQVNASRTRITFV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MALKDYALE
------CCHHHHHHH
24.2622223895
4Sumoylation----MALKDYALEKE
----CCHHHHHHHHH
38.87-
42-Hydroxyisobutyrylation----MALKDYALEKE
----CCHHHHHHHHH
38.87-
4Acetylation----MALKDYALEKE
----CCHHHHHHHHH
38.8725953088
4Succinylation----MALKDYALEKE
----CCHHHHHHHHH
38.8723954790
4Sumoylation----MALKDYALEKE
----CCHHHHHHHHH
38.87-
4Ubiquitination----MALKDYALEKE
----CCHHHHHHHHH
38.87-
6Phosphorylation--MALKDYALEKEKV
--CCHHHHHHHHHHH
16.1120068231
10SumoylationLKDYALEKEKVKKFL
HHHHHHHHHHHHHHH
64.78-
10SuccinylationLKDYALEKEKVKKFL
HHHHHHHHHHHHHHH
64.7823954790
10SumoylationLKDYALEKEKVKKFL
HHHHHHHHHHHHHHH
64.78-
10UbiquitinationLKDYALEKEKVKKFL
HHHHHHHHHHHHHHH
64.78-
10 (in isoform 1)Ubiquitination-64.7821890473
10 (in isoform 2)Ubiquitination-64.7821890473
12UbiquitinationDYALEKEKVKKFLQE
HHHHHHHHHHHHHHH
71.12-
15UbiquitinationLEKEKVKKFLQEFYQ
HHHHHHHHHHHHHHC
55.0521890473
15SumoylationLEKEKVKKFLQEFYQ
HHHHHHHHHHHHHHC
55.05-
15SumoylationLEKEKVKKFLQEFYQ
HHHHHHHHHHHHHHC
55.0528112733
15UbiquitinationLEKEKVKKFLQEFYQ
HHHHHHHHHHHHHHC
55.0521890473
15 (in isoform 1)Ubiquitination-55.0521890473
15 (in isoform 2)Ubiquitination-55.0521890473
21NitrationKKFLQEFYQDDELGK
HHHHHHHHCCCHHHH
15.41-
21PhosphorylationKKFLQEFYQDDELGK
HHHHHHHHCCCHHHH
15.4128152594
28AcetylationYQDDELGKKQFKYGN
HCCCHHHHHHHHHHH
56.9023954790
28SumoylationYQDDELGKKQFKYGN
HCCCHHHHHHHHHHH
56.9028112733
28UbiquitinationYQDDELGKKQFKYGN
HCCCHHHHHHHHHHH
56.9021890473
28 (in isoform 1)Ubiquitination-56.9021890473
28 (in isoform 2)Ubiquitination-56.9021890473
29UbiquitinationQDDELGKKQFKYGNQ
CCCHHHHHHHHHHHH
60.2021890473
29AcetylationQDDELGKKQFKYGNQ
CCCHHHHHHHHHHHH
60.2030590355
29UbiquitinationQDDELGKKQFKYGNQ
CCCHHHHHHHHHHHH
60.2022053931
29 (in isoform 1)Ubiquitination-60.2021890473
29 (in isoform 2)Ubiquitination-60.2021890473
32SumoylationELGKKQFKYGNQLVR
HHHHHHHHHHHHHHH
50.16-
32SumoylationELGKKQFKYGNQLVR
HHHHHHHHHHHHHHH
50.16-
32UbiquitinationELGKKQFKYGNQLVR
HHHHHHHHHHHHHHH
50.16-
33PhosphorylationLGKKQFKYGNQLVRL
HHHHHHHHHHHHHHH
23.6928152594
55UbiquitinationLYVDLDDVAEDDPEL
EEEEHHHHHCCCHHH
6.6621890473
75UbiquitinationENARRYAKLFADAVQ
HHHHHHHHHHHHHHH
34.8921890473
75UbiquitinationENARRYAKLFADAVQ
HHHHHHHHHHHHHHH
34.8921890473
75 (in isoform 1)Ubiquitination-34.8921890473
75 (in isoform 2)Ubiquitination-34.8921890473
89UbiquitinationQELLPQYKEREVVNK
HHHHHHHHHHHCCCH
45.08890473
89 (in isoform 1)Ubiquitination-45.0821890473
89 (in isoform 2)Ubiquitination-45.0821890473
962-HydroxyisobutyrylationKEREVVNKDVLDVYI
HHHHCCCHHHHHHHH
37.29-
96AcetylationKEREVVNKDVLDVYI
HHHHCCCHHHHHHHH
37.2926822725
96UbiquitinationKEREVVNKDVLDVYI
HHHHCCCHHHHHHHH
37.29-
102PhosphorylationNKDVLDVYIEHRLMM
CHHHHHHHHHHHHHH
10.5627642862
113PhosphorylationRLMMEQRSRDPGMVR
HHHHHHHCCCCCCCC
40.5020068231
121PhosphorylationRDPGMVRSPQNQYPA
CCCCCCCCCCCCCCH
21.3022167270
126PhosphorylationVRSPQNQYPAELMRR
CCCCCCCCCHHHHHH
16.3828450419
137PhosphorylationLMRRFELYFQGPSSN
HHHHHEEEECCCCCC
6.1528152594
145UbiquitinationFQGPSSNKPRVIREV
ECCCCCCCCCEEEEE
35.8321890473
145UbiquitinationFQGPSSNKPRVIREV
ECCCCCCCCCEEEEE
35.8322053931
145 (in isoform 1)Ubiquitination-35.8321890473
145 (in isoform 2)Ubiquitination-35.8321890473
156PhosphorylationIREVRADSVGKLVTV
EEEEECCCCCCEEEE
31.6123401153
159SumoylationVRADSVGKLVTVRGI
EECCCCCCEEEEEEE
37.31-
1592-HydroxyisobutyrylationVRADSVGKLVTVRGI
EECCCCCCEEEEEEE
37.31-
159AcetylationVRADSVGKLVTVRGI
EECCCCCCEEEEEEE
37.3125953088
159SumoylationVRADSVGKLVTVRGI
EECCCCCCEEEEEEE
37.31-
159UbiquitinationVRADSVGKLVTVRGI
EECCCCCCEEEEEEE
37.3121906983
159 (in isoform 1)Ubiquitination-37.3121890473
159 (in isoform 2)Ubiquitination-37.3121890473
168PhosphorylationVTVRGIVTRVSEVKP
EEEEEEEEEHHHCCC
24.35-
174SumoylationVTRVSEVKPKMVVAT
EEEHHHCCCCEEEEE
34.56-
174SumoylationVTRVSEVKPKMVVAT
EEEHHHCCCCEEEEE
34.56-
174UbiquitinationVTRVSEVKPKMVVAT
EEEHHHCCCCEEEEE
34.56-
219MethylationQTNRSGGRLYLQTRG
CCCCCCCEEEEEECC
24.55115483003
225MethylationGRLYLQTRGSRFIKF
CEEEEEECCCCCEEH
28.29115482987
231UbiquitinationTRGSRFIKFQEMKMQ
ECCCCCEEHHHHHCH
37.9821890473
231SumoylationTRGSRFIKFQEMKMQ
ECCCCCEEHHHHHCH
37.98-
231SumoylationTRGSRFIKFQEMKMQ
ECCCCCEEHHHHHCH
37.98-
231UbiquitinationTRGSRFIKFQEMKMQ
ECCCCCEEHHHHHCH
37.9821890473
231 (in isoform 1)Ubiquitination-37.9821890473
231 (in isoform 2)Ubiquitination-37.9821890473
236SumoylationFIKFQEMKMQEHSDQ
CEEHHHHHCHHCCCC
36.36-
236AcetylationFIKFQEMKMQEHSDQ
CEEHHHHHCHHCCCC
36.3625953088
236SumoylationFIKFQEMKMQEHSDQ
CEEHHHHHCHHCCCC
36.36-
236UbiquitinationFIKFQEMKMQEHSDQ
CEEHHHHHCHHCCCC
36.3621906983
236 (in isoform 1)Ubiquitination-36.3621890473
236 (in isoform 2)Ubiquitination-36.3621890473
237SulfoxidationIKFQEMKMQEHSDQV
EEHHHHHCHHCCCCC
5.6528183972
272PhosphorylationAQPGDHVSVTGIFLP
CCCCCEEEEEEEHHH
15.5628450419
274PhosphorylationPGDHVSVTGIFLPIL
CCCEEEEEEEHHHHH
19.6328450419
294PhosphorylationQVVQGLLSETYLEAH
HHHHHHHCHHHHHHH
32.7028152594
296PhosphorylationVQGLLSETYLEAHRI
HHHHHCHHHHHHHHH
29.9928152594
297PhosphorylationQGLLSETYLEAHRIV
HHHHCHHHHHHHHHE
9.8628152594
305UbiquitinationLEAHRIVKMNKSEDD
HHHHHHEECCCCCCC
34.0921906983
305 (in isoform 1)Ubiquitination-34.0921890473
305 (in isoform 2)Ubiquitination-34.0921890473
306SulfoxidationEAHRIVKMNKSEDDE
HHHHHEECCCCCCCC
5.4521406390
308SumoylationHRIVKMNKSEDDESG
HHHEECCCCCCCCCC
52.29-
308AcetylationHRIVKMNKSEDDESG
HHHEECCCCCCCCCC
52.2926822725
308SumoylationHRIVKMNKSEDDESG
HHHEECCCCCCCCCC
52.29-
308UbiquitinationHRIVKMNKSEDDESG
HHHEECCCCCCCCCC
52.2921906983
308 (in isoform 1)Ubiquitination-52.2921890473
308 (in isoform 2)Ubiquitination-52.2921890473
309PhosphorylationRIVKMNKSEDDESGA
HHEECCCCCCCCCCC
41.0520873877
314PhosphorylationNKSEDDESGAGELTR
CCCCCCCCCCCCCCH
40.7223401153
320PhosphorylationESGAGELTREELRQI
CCCCCCCCHHHHHHH
31.5625159151
321MethylationSGAGELTREELRQIA
CCCCCCCHHHHHHHH
48.2829151839
325MethylationELTREELRQIAEEDF
CCCHHHHHHHHHHHH
29.19115482955
333PhosphorylationQIAEEDFYEKLAASI
HHHHHHHHHHHHHHH
25.1929978859
335UbiquitinationAEEDFYEKLAASIAP
HHHHHHHHHHHHHCH
31.8521906983
335 (in isoform 1)Ubiquitination-31.8521890473
351AcetylationIYGHEDVKKALLLLL
HHCCHHHHHHHHHHH
44.6525953088
351SuccinylationIYGHEDVKKALLLLL
HHCCHHHHHHHHHHH
44.6523954790
351SumoylationIYGHEDVKKALLLLL
HHCCHHHHHHHHHHH
44.65-
351UbiquitinationIYGHEDVKKALLLLL
HHCCHHHHHHHHHHH
44.65-
351 (in isoform 1)Ubiquitination-44.6521890473
352UbiquitinationYGHEDVKKALLLLLV
HCCHHHHHHHHHHHH
44.08-
365PhosphorylationLVGGVDQSPRGMKIR
HHCCCCCCCCCCEEC
16.4619647517
378GlutathionylationIRGNINICLMGDPGV
ECCCEEEEECCCCCC
1.5322555962
381UbiquitinationNINICLMGDPGVAKS
CEEEEECCCCCCCHH
25.6421890473
387UbiquitinationMGDPGVAKSQLLSYI
CCCCCCCHHHHHHHH
36.0122053931
387 (in isoform 1)Ubiquitination-36.0121890473
388PhosphorylationGDPGVAKSQLLSYID
CCCCCCHHHHHHHHH
19.1421712546
392PhosphorylationVAKSQLLSYIDRLAP
CCHHHHHHHHHHHCC
28.7428152594
393PhosphorylationAKSQLLSYIDRLAPR
CHHHHHHHHHHHCCH
13.5528152594
396MethylationQLLSYIDRLAPRSQY
HHHHHHHHHCCHHHC
24.16115483011
407MethylationRSQYTTGRGSSGVGL
HHHCCCCCCCCCCCC
39.46115483019
409PhosphorylationQYTTGRGSSGVGLTA
HCCCCCCCCCCCCCE
23.6621406692
410PhosphorylationYTTGRGSSGVGLTAA
CCCCCCCCCCCCCEE
40.0821406692
415PhosphorylationGSSGVGLTAAVLRDS
CCCCCCCCEEHHHCC
13.4721406692
420UbiquitinationGLTAAVLRDSVSGEL
CCCEEHHHCCCCCEE
27.7921890473
449"N6,N6-dimethyllysine"CCIDEFDKMAEADRT
EEEHHHHHHHHHHHH
45.38-
449MethylationCCIDEFDKMAEADRT
EEEHHHHHHHHHHHH
45.3823583077
462SulfoxidationRTAIHEVMEQQTISI
HHHHHHHHHHHCHHH
3.3328183972
471UbiquitinationQQTISIAKAGILTTL
HHCHHHHHHCHHHHH
45.5422053931
471 (in isoform 1)Ubiquitination-45.5421890473
472UbiquitinationQTISIAKAGILTTLN
HCHHHHHHCHHHHHH
10.9621890473
482GlutathionylationLTTLNARCSILAAAN
HHHHHHHHHHHHHHC
2.4922555962
482S-nitrosylationLTTLNARCSILAAAN
HHHHHHHHHHHHHHC
2.4924105792
483PhosphorylationTTLNARCSILAAANP
HHHHHHHHHHHHHCC
18.3227080861
492PhosphorylationLAAANPAYGRYNPRR
HHHHCCCCCCCCCCC
11.9128152594
500PhosphorylationGRYNPRRSLEQNIQL
CCCCCCCCHHHHCCC
37.2226055452
524MethylationLLWLIQDRPDRDNDL
EEHHHCCCCCCCCHH
20.74115482979
527MethylationLIQDRPDRDNDLRLA
HHCCCCCCCCHHHHH
47.52115482971
532MethylationPDRDNDLRLAQHITY
CCCCCHHHHHHHHHH
30.73115482947
538PhosphorylationLRLAQHITYVHQHSR
HHHHHHHHHHHHCCC
19.8428152594
539PhosphorylationRLAQHITYVHQHSRQ
HHHHHHHHHHHCCCC
8.7128152594
544PhosphorylationITYVHQHSRQPPSQF
HHHHHHCCCCCCHHC
26.4928152594
549PhosphorylationQHSRQPPSQFEPLDM
HCCCCCCHHCCCCCH
54.9417525332
556SulfoxidationSQFEPLDMKLMRRYI
HHCCCCCHHHHHHHH
4.7721406390
557UbiquitinationQFEPLDMKLMRRYIA
HCCCCCHHHHHHHHH
38.5121890473
557UbiquitinationQFEPLDMKLMRRYIA
HCCCCCHHHHHHHHH
38.5121890473
557 (in isoform 1)Ubiquitination-38.5121890473
569UbiquitinationYIAMCREKQPMVPES
HHHHHHHCCCCCCHH
40.1121906983
569 (in isoform 1)Ubiquitination-40.1121890473
576PhosphorylationKQPMVPESLADYITA
CCCCCCHHHHHHHHH
23.8420068231
580PhosphorylationVPESLADYITAAYVE
CCHHHHHHHHHHHHH
8.4520068231
582PhosphorylationESLADYITAAYVEMR
HHHHHHHHHHHHHHH
10.0620068231
585PhosphorylationADYITAAYVEMRREA
HHHHHHHHHHHHHHH
8.4220068231
596UbiquitinationRREAWASKDATYTSA
HHHHHHCCCCCHHHH
43.5721890473
5962-HydroxyisobutyrylationRREAWASKDATYTSA
HHHHHHCCCCCHHHH
43.57-
596AcetylationRREAWASKDATYTSA
HHHHHHCCCCCHHHH
43.5726051181
596UbiquitinationRREAWASKDATYTSA
HHHHHHCCCCCHHHH
43.5721890473
596 (in isoform 1)Ubiquitination-43.5721890473
599PhosphorylationAWASKDATYTSARTL
HHHCCCCCHHHHHHH
37.15-
600PhosphorylationWASKDATYTSARTLL
HHCCCCCHHHHHHHH
10.6225884760
601PhosphorylationASKDATYTSARTLLA
HCCCCCHHHHHHHHH
16.1428152594
605PhosphorylationATYTSARTLLAILRL
CCHHHHHHHHHHHHH
26.32-
613PhosphorylationLLAILRLSTALARLR
HHHHHHHHHHHHHCC
12.7525367160
614PhosphorylationLAILRLSTALARLRM
HHHHHHHHHHHHCCC
30.2225367160
621SulfoxidationTALARLRMVDVVEKE
HHHHHCCCCCEECHH
3.4121406390
6272-HydroxyisobutyrylationRMVDVVEKEDVNEAI
CCCCEECHHCHHHHH
47.83-
627AcetylationRMVDVVEKEDVNEAI
CCCCEECHHCHHHHH
47.8326051181
627UbiquitinationRMVDVVEKEDVNEAI
CCCCEECHHCHHHHH
47.8321906983
627 (in isoform 1)Ubiquitination-47.8321890473
640PhosphorylationAIRLMEMSKDSLLGD
HHHHHHHCHHHHCCC
21.7226657352
6412-HydroxyisobutyrylationIRLMEMSKDSLLGDK
HHHHHHCHHHHCCCC
50.45-
641UbiquitinationIRLMEMSKDSLLGDK
HHHHHHCHHHHCCCC
50.4521906983
641 (in isoform 1)Ubiquitination-50.4521890473
643PhosphorylationLMEMSKDSLLGDKGQ
HHHHCHHHHCCCCCC
29.2726657352
648UbiquitinationKDSLLGDKGQTARTQ
HHHHCCCCCCCCCCC
51.6321890473
648AcetylationKDSLLGDKGQTARTQ
HHHHCCCCCCCCCCC
51.6325953088
648UbiquitinationKDSLLGDKGQTARTQ
HHHHCCCCCCCCCCC
51.6322053931
648 (in isoform 1)Ubiquitination-51.6321890473
670PhosphorylationATVRELVSGGRSVRF
EEHHHHHHCCCCCCC
48.4224719451
673MethylationRELVSGGRSVRFSEA
HHHHHCCCCCCCCHH
35.19115482963
674PhosphorylationELVSGGRSVRFSEAE
HHHHCCCCCCCCHHH
22.4023312004
678PhosphorylationGGRSVRFSEAEQRCV
CCCCCCCCHHHHHHH
25.9023911959

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
121SPhosphorylationKinaseCDK1P06493
PSP
121SPhosphorylationKinaseCDK2P24941
PSP
365SPhosphorylationKinaseCDK1P06493
PSP
365SPhosphorylationKinaseCDK2P24941
PSP
600YPhosphorylationKinaseLYNP07948
PSP
-KUbiquitinationE3 ubiquitin ligaseUBE3AQ05086
PMID:9852095

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MCM7_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MCM7_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ORC1_HUMANORC1physical
12614612
RB_HUMANRB1physical
9566894
DBF4A_HUMANDBF4physical
12614612
CDC7_HUMANCDC7physical
12614612
ORC3_HUMANORC3physical
12614612
RFA1_HUMANRPA1physical
12614612
FHL2_HUMANFHL2physical
10649446
ORC2_HUMANORC2physical
12614612
ORC5_HUMANORC5physical
12614612
RBM8A_HUMANRBM8Aphysical
16189514
MBIP1_HUMANMBIPphysical
16189514
MCM7_HUMANMCM7physical
12614612
ATR_HUMANATRphysical
15210935
MCM8_HUMANMCM8physical
12771218
MCM2_HUMANMCM2physical
12694531
MCM7_HUMANMCM7physical
12694531
MCM2_HUMANMCM2physical
12614612
MCM3_HUMANMCM3physical
12614612
MCM6_HUMANMCM6physical
12614612
CDC6_HUMANCDC6physical
12614612
CDC45_HUMANCDC45physical
12614612
CDC45_HUMANCDC45physical
10518787
CDC6_HUMANCDC6physical
10464337
MCM3_HUMANMCM3physical
10464337
UBE3A_HUMANUBE3Aphysical
9852095
MCM4_HUMANMCM4physical
9099751
MCM5_HUMANMCM5physical
9099751
MCM6_HUMANMCM6physical
9099751
MCM3_HUMANMCM3physical
9099751
MCM2_HUMANMCM2physical
9099751
MCM4_HUMANMCM4physical
12207017
MCM2_HUMANMCM2physical
12207017
CDC45_HUMANCDC45physical
16912045
RB_HUMANRB1physical
16912045
CCL2_HUMANCCL2physical
21383955
HIF1A_HUMANHIF1Aphysical
21658608
EPAS1_HUMANEPAS1physical
21658608
RB_HUMANRB1physical
12519773
INT6_HUMANINTS6physical
17310990
A4_HUMANAPPphysical
21832049
SMC1A_HUMANSMC1Aphysical
22939629
SF3A1_HUMANSF3A1physical
22939629
RBBP4_HUMANRBBP4physical
22939629
RU2A_HUMANSNRPA1physical
22939629
ORC4_HUMANORC4physical
15232106
MCM10_HUMANMCM10physical
15232106
MCM2_HUMANMCM2physical
15232106
ORC6_HUMANORC6physical
15232106
MCM4_HUMANMCM4physical
15232106
SMC1A_HUMANSMC1Aphysical
16438930
HS90B_HUMANHSP90AB1physical
22863883
HYOU1_HUMANHYOU1physical
22863883
CLU_HUMANCLUHphysical
22863883
MCM2_HUMANMCM2physical
22863883
MCM4_HUMANMCM4physical
22863883
ANM1_HUMANPRMT1physical
22863883
TOM34_HUMANTOMM34physical
22863883
NAB2_HUMANNAB2physical
25416956
TRI27_HUMANTRIM27physical
25416956
SP2_HUMANSP2physical
25416956
PNMA1_HUMANPNMA1physical
25416956
UBQL1_HUMANUBQLN1physical
25416956
MBIP1_HUMANMBIPphysical
25416956
TRI54_HUMANTRIM54physical
25416956
C102B_HUMANCCDC102Bphysical
25416956
MCMBP_HUMANMCMBPphysical
25416956
USBP1_HUMANUSHBP1physical
25416956
CH034_HUMANC8orf34physical
25416956
MIPO1_HUMANMIPOL1physical
25416956
KAD8_HUMANAK8physical
25416956
VPS29_HUMANVPS29physical
26186194
VPS35_HUMANVPS35physical
26186194
MCM2_HUMANMCM2physical
26186194
TIM_HUMANTIMELESSphysical
26186194
DAPLE_HUMANCCDC88Cphysical
26186194
VP26A_HUMANVPS26Aphysical
26186194
HDAC6_HUMANHDAC6physical
26186194
CE290_HUMANCEP290physical
26186194
PSF2_HUMANGINS2physical
26186194
SLD5_HUMANGINS4physical
26186194
TCPD_HUMANCCT4physical
26344197
MARE2_HUMANMAPRE2physical
26344197
MCMBP_HUMANMCMBPphysical
26344197
PSMD2_HUMANPSMD2physical
26344197
SF3B1_HUMANSF3B1physical
26344197
KCTD5_HUMANKCTD5physical
26188516
CUL3_HUMANCUL3physical
26188516
DAPLE_HUMANCCDC88Cphysical
28514442
VP26A_HUMANVPS26Aphysical
28514442
TIM_HUMANTIMELESSphysical
28514442
PSF2_HUMANGINS2physical
28514442
VPS35_HUMANVPS35physical
28514442
HDAC6_HUMANHDAC6physical
28514442
CE290_HUMANCEP290physical
28514442
SLD5_HUMANGINS4physical
28514442
VPS29_HUMANVPS29physical
28514442
PSF1_HUMANGINS1physical
28514442
UBP15_HUMANUSP15physical
27173435
MCM2_HUMANMCM2physical
27173435
MCM4_HUMANMCM4physical
27173435
MCM6_HUMANMCM6physical
27173435
FANCA_HUMANFANCAphysical
28215707
CEP68_HUMANCEP68physical
28578000
GRWD1_HUMANGRWD1physical
25990725
CDT1_HUMANCDT1physical
25990725
CDC6_HUMANCDC6physical
25990725

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MCM7_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-500, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-500, ANDMASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-500, ANDMASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-549, AND MASSSPECTROMETRY.

TOP